This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cerner Innovation, Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Robert Charles Amland
Introduction
Robert Charles Amland is a notable inventor based in Lenexa, KS (US). He has made significant contributions to the field of healthcare through his innovative patent. His work focuses on improving patient care and reducing hospital readmission rates.
Latest Patents
Amland holds a patent for a readmission risk assessment model. This model is designed to predict the risk of patient readmission to hospitals. It identifies patients at elevated risk and informs both inpatient treatment and outpatient activities based on this risk. The model utilizes logistic regression techniques to generate predictions for various clinical conditions. When a patient is admitted, their condition is assessed, and the corresponding readmission risk prediction model is applied. This information is crucial for clinicians, as it helps recommend interventions aimed at reducing the likelihood of readmission. Additionally, the readmission risk can be calculated post-discharge to assist in planning outpatient care.
Career Highlights
Amland is currently associated with Cerner Innovation, Inc., where he continues to develop innovative solutions in healthcare technology. His work is instrumental in enhancing patient outcomes and streamlining healthcare processes.
Collaborations
Amland collaborates with talented professionals, including Jason Howard and Hugh H. Ryan. Their combined expertise contributes to the advancement of healthcare innovations.
Conclusion
Robert Charles Amland's contributions to healthcare through his patent on readmission risk assessment exemplify the impact of innovation in improving patient care. His work continues to influence the healthcare industry positively.